HomeCompareCHYMF vs JNJ

CHYMF vs JNJ: Dividend Comparison 2026

CHYMF yields 2.34% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $7.4K in total portfolio value· pulled ahead in Year 7
10 years
CHYMF
CHYMF
● Live price
2.34%
Share price
$0.30
Annual div
$0.01
5Y div CAGR
-0.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.1K
Annual income
$260.58
Full CHYMF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CHYMF vs JNJ

📍 JNJ pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHYMFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHYMF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CHYMF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHYMF
Annual income on $10K today (after 15% tax)
$198.76/yr
After 10yr DRIP, annual income (after tax)
$221.49/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $3,815.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHYMF + JNJ for your $10,000?

CHYMF: 50%JNJ: 50%
100% JNJ50/50100% CHYMF
Portfolio after 10yr
$26.8K
Annual income
$2,505.23/yr
Blended yield
9.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CHYMF
No analyst data
Altman Z
2.0
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHYMF buys
0
JNJ buys
0
No recent congressional trades found for CHYMF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHYMFJNJ
Forward yield2.34%2.14%
Annual dividend / share$0.01$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-0.4%28%
Portfolio after 10y$23.1K$30.5K
Annual income after 10y$260.58$4,749.88
Total dividends collected$2.5K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CHYMF vs JNJ ($10,000, DRIP)

YearCHYMF PortfolioCHYMF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,933$232.90$10,594$274.49+$339.00CHYMF
2$11,935$237.02$11,294$360.69+$641.00CHYMF
3$13,012$240.86$12,133$476.91+$879.00CHYMF
4$14,167$244.42$13,156$635.42+$1.0KCHYMF
5$15,406$247.71$14,432$854.61+$974.00CHYMF
6$16,735$250.76$16,056$1,162.76+$679.00CHYMF
7← crossover$18,160$253.55$18,175$1,604.53$15.00JNJ
8$19,688$256.11$21,009$2,252.68$1.3KJNJ
9$21,324$258.45$24,911$3,229.73$3.6KJNJ
10$23,078$260.58$30,458$4,749.88$7.4KJNJ

CHYMF vs JNJ: Complete Analysis 2026

CHYMFStock

Cahya Mata Sarawak Berhad, an investment holding company, engages in the manufacturing and trading of cement and construction materials, construction, road maintenance, township, and property and infrastructure development businesses in Malaysia. It operates through seven segments: Cement, Construction Materials and Trading, Road Maintenance, Construction, Property Development, Phosphate, and Samalaju Development. The company offers Portland cement; clinker and ready-mix concrete products; pre-cast concrete products, including pre-stressed beams for bridges and other uses, reinforced concrete square piles, box culverts, kerbs, and cement sand bricks; and industrialized building systems, such as wall panels, pre-cast columns and beams, half slabs, hollow blocks, and staircases. It also provides microtonalite, granite, and limestone; delivery, grading, and pavement laying services; steel drawn wires and wire mesh; residential, commercial, and township development, management, and consultancy services; management of temporary accommodation services; supervisory, general trading, software and IT support, education, technical, machinery, and motor vehicle rental services; rehabilitation and maintenance for roads; and construction and road maintenance equipment, as well as supplies premix and road maintenance contractor works. In addition, the company undertakes general construction and infrastructure projects; distributes road and general construction materials, water treatment materials, electrical pipes equipment, and mechanical spare parts; rents investment properties; owns and operates hotels and lodges; and manufactures food, feed, and fertilizer phosphate products. Further, it engages in the mixed-use development and project management activities; and construction of telecommunication towers, as well as undertakes civil engineering, building, and utilities works. The company was founded in 1974 and is headquartered in Kuching, Malaysia.

Full CHYMF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CHYMF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHYMF vs SCHDCHYMF vs JEPICHYMF vs OCHYMF vs KOCHYMF vs MAINCHYMF vs ABBVCHYMF vs MRKCHYMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.